Details

Autor(en) / Beteiligte

• Yapici, Unsal
• Bemelman, Fréderike J
• Scheepstra, Cornelis G
• Roelofs, Joris J T H
• Claessen, Nike
• van der Loos, Chris
• van Donselaar-van der Pant, Karlijn
• Bouts, Antonia H M
• Idu, Mirza M
• Rowshani, Ajda T
• ten Berge, Ineke J M
• Florquin, Sandrine

Titel

Intragraft FOXP3 protein or mRNA during acute renal allograft rejection correlates with inflammation, fibrosis, and poor renal outcome

Ist Teil von

• Transplantation, 2009-05, Vol.87 (9), p.1377-1380

Ort / Verlag

United States

Erscheinungsjahr

2009

Quelle

MEDLINE

Beschreibungen/Notizen

• Forkhead box (FOXP3) is considered to be a specific marker for regulatory T cells. The aim of this study was to correlate intragraft FOXP3 at mRNA and cellular levels during renal allograft rejection to response to therapy and late clinical outcome. Immunostainings and quantitative reverse-transcriptase polymerase chain reaction for FOXP3, CD3, and transforming growth factor (TGF)-beta were performed and results were related to histopathologic and clinical outcome. A good correlation between immunohistochemical analysis and mRNA levels for both CD3 and FOXP3 was observed. Intragraft FOXP3 was significantly related to tubulitis and interstitial fibrosis. A strong correlation was found between FOXP3 and CD3 mRNA and between FOXP3 and TGF-beta mRNA. No correlation was found between FOXP3 and response to therapy. In conclusion, intragraft FOXP3 at both cellular and molecular levels parallels T-cell infiltration during acute rejection. FOXP3 does not predict response to antirejection therapy. FOXP3 correlates with renal fibrosis, TGF-beta, and poor late renal outcome.